XML 38 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Anti-dilutive stock awards were as follows for the periods presented:
Quarter Ended
September 30,
Nine Months Ended
September 30,
(in thousands)2023202220232022
Stock awards333 102 373 107 
Total333 102 373 107 
Basic And Diluted Earnings Per Share
The following table presents the earnings per share calculation for the periods presented:
 Quarter Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Net Income (in millions)
$750.2 $679.6 $2,411.6 $2,053.1 
Less: preferred stock dividends(5.0)(4.6)(15.1)(13.8)
Less: undistributed earnings allocated to preferred stock(4.4)(3.9)(15.2)(12.1)
Net Income Attributable to Common Shareholders of CME Group$740.8 $671.1 $2,381.3 $2,027.2 
Weighted Average Number of Common Shares (in thousands):
Basic359,020 358,715 358,965 358,655 
Effect of stock options, restricted stock and performance shares599 573 483 551 
Diluted359,619 359,288 359,448 359,206 
Earnings per Common Share Attributable to Common Shareholders of CME Group:
Basic$2.06 $1.87 $6.63 $5.65 
Diluted2.06 1.87 6.62 5.64